Accuray Incorporated and RaySearch Laboratories have expanded their collaboration to accelerate the adoption of online adaptive radiation therapy, combining Accuray's radiation platforms with RaySearch's treatment planning software. The initial focus is on Accuray's Radixact system, with plans to extend to the CyberKnife platform. This technology allows treatment plans to be adjusted in real-time based on patient anatomy, aiming to provide more personalized and efficient cancer treatments. Accuray will purchase $8 million in RayStation licenses to support commercialization, and both companies will jointly market and support the solutions.
Swiss company AirConsole has partnered with Zeekr, a premium electric vehicle brand under Geely Auto Group, to introduce in-car gaming integrated into Zeekr's infotainment systems. The partnership debuted at the 2026 Paris Motor Show, showcasing game...
Bouygues Telecom has signed a long-term strategic partnership with iBASIS to handle its international voice wholesale, IPX, and managed roaming services. This deal makes Bouygues Telecom the first independent European operator to fully outsource its ...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share dealings on October 12, 2026. The bank purchased 16,108 ordinary shares at a price of 282.25 per share and sold 141 shares at the same ...
At the 2026 Paris Motor Show, Chery introduced its "For EU. For Family" strategy, tailored to meet European families' mobility needs with a focus on space, safety, and technology. The company showcased a range of vehicles including its first battery-...
Publicis Groupe delivered a robust Q3 2026 with a 5% organic growth in net revenue, accelerating from the first half of the year. Key growth drivers included Connected Media and Intelligent Creativity, fueled by AI-driven services and strong new busi...
